Modified Anatomical Mesh In The Management Of Orbito-Zygomatico-Maxillary Complex Fractures
1 other identifier
interventional
24
1 country
1
Brief Summary
Orbito-Zygomaticomaxillary-complex fractures is a form of a complex orbital floor fracture, with affection of the inferior orbital rim and the orbital walls. According to published research, between 67 - 84 % of periorbital bone fractures are orbital floor fractures. Evaluation of 3D-Modified Anatomic Mesh in the management of OZM- complex fractures with orbital floor defect, and compare it with the conventional fixation configuration.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2025
CompletedFirst Submitted
Initial submission to the registry
April 16, 2025
CompletedFirst Posted
Study publicly available on registry
May 6, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2025
CompletedDecember 31, 2025
April 1, 2025
5 months
April 16, 2025
December 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Radiographic assessment of the management of the Orbito-Zygomaticomaxillary Complex fracture
Radiographic assessment of the management of the Orbito-Zygomaticomaxillary Complex fracture
1 week
Secondary Outcomes (1)
Periorbital ecchymosis
6 weeks
Study Arms (2)
Patients with Orbito-Zygomaticomaxillary Complex fracture managed with 3D-Modified Anatomical-Mesh
ACTIVE COMPARATORPatients with Orbito-Zygomaticomaxillary Complex fracture managed with 3D-Modified Anatomical-Mesh
Patients with Orbito-Zygomaticomaxillary Complex fracture managed with conventional orbital rim mini
EXPERIMENTALPatients with Orbito-Zygomaticomaxillary Complex fracture managed with conventional orbital rim mini
Interventions
3D-Modified Anatomical-Mesh.
conventional orbital rim miniplates and orbital mesh configuration
Eligibility Criteria
You may qualify if:
- Patients suffering from Orbito-Zygomaticomaxillary complex fractures with fracture in the orbital floor and orbital floor defect(16).
- Fractures that are indicated for open reduction and internal fixation.
- Patients suffering from ocular complications:
- Monocular diplopia.
- Enophthalmos above 2 mm.
- Restricted ocular motility.
- Patients with orbital wall defects with orbital soft tissue herniation into the maxillary sinus.
- Adult patient either male or female that agrees to present for follow-up visits for an adequate postoperative period.
You may not qualify if:
- Patients with isolated orbital floor defects and blowout fractures.
- Patients with isolated zygomatico-maxillary complex fracture with no orbital floor/ walls defects.
- Patients with bilateral orbital defects.
- Patients with Infected wounds in periorbital region.
- Medically compromised patients rendering them inoperable.
- Patients with ruptured globe or blindness.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Dentistry, Alexandria University
Alexandria, Alexandria Governorate, 21523, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Sequentially numbered, opaque, sealed envelopes (SNOSE) allocation concealment method will be utilized. Each participant included in the study will be given a serial number that will be used in the allocation. These numbers will be written in identical sheets of paper with the group to which each participant is allocated and placed inside opaque envelopes carrying the respective names of participants. A trial independent personnel will be assigned the role of keeping the envelopes and unfolding them only at the time of the operation, so that the participant is allocated to a group which is concealed from the operator
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 16, 2025
First Posted
May 6, 2025
Study Start
October 1, 2024
Primary Completion
March 1, 2025
Study Completion
June 15, 2025
Last Updated
December 31, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- SAP
- Access Criteria
- to any one who required them after deidentification
all data will be de-identified to protect the participant data. patients signed an informed consent for the use of their medical records and data for study